Skip to main navigation Skip to search Skip to main content

Long-term Efficacy and Safety of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results From a Phase III

  • Hermine Brunner
  • , Nicolino Ruperto
  • , Pierre Quartier
  • , Tamas Constantin
  • , Ekaterina Alexeeva
  • , Isabelle Kone-Paut
  • , Katherine Marzan
  • , Nico Wulffraat
  • , Rayfel Schneider
  • , Shai Padeh
  • , Vyacheslav Chasnyk
  • , Carine Wouters
  • , Jasmin B. Kuemmerle-Deschner
  • , Tilmann Kallinich
  • , Bernard Lauwerys
  • , Elie Haddad
  • , Evgeny L. Nasonov
  • , Maria Trachana
  • , Olga Vougiouka
  • , Karolynn Leon
  • Eleni Vritzali, Karine Lheritier, Alberto Martini, Daniel Lovell

Research output: Contribution to journal › Meeting Abstract › Academic

Original languageEnglish
Pages (from-to)64-66
JournalArthritis & Rheumatology
Volume69
Publication statusPublished - Apr 2017

Cite this